A few days ago, the world's first new drug for the treatment of Alzheimer's disease, which only needs to be injected once a month, donemab injection, was successfully prescribed in Xuanwu Hospital of Capital Medical University and the National Medical Center for Neurological Diseases. At the same time, 5 patients were also treated with the drug at the same time, bringing a new dawn of hope to their lives.

阿爾茨海默病會致使記憶力與其他認知功能漸進式衰退，是致命疾病，當下有效治療手段較為匱乏。據權威數據，中國約有983萬阿爾茨海默病患者。隨著人口老齡化加劇，該病已成為我國沉重的醫療負擔。為患者探尋更優治療方案、有效控制病情，是眾多醫學研究者面臨的難題。

In recent years, thanks to the progress of diagnostic technology and breakthroughs in mechanism research, medical science and technology innovation has injected strong impetus into the prevention and treatment of Alzheimer's disease. In Xuanwu Hospital, the R&D and application of these new drugs have not only brought more hope to patients, but also opened up a new path for clinical treatment. (Editor-in-charge: Liu Xiao)